AstraZeneca (AZN) Tops Q1 EPS by 20c
Tweet
Share
E-mail
Get Alerts AZN Hot Sheet
Join SI Premium – FREE
AstraZeneca (NASDAQ: AZN) reported Q1 EPS of $1.92, $0.20 better than the analyst estimate of $1.72. Revenue for the quarter came in at $10.88 billion versus the consensus estimate of $10.69 billion.
For earnings history and earnings-related data on AstraZeneca (AZN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SLM (SLM) Misses Q2 EPS by 16c; offers guidance
- Alpine Income Property Trust, Inc. (PINE) Tops Q2 EPS by 2c; Offers Guidance
- Marten Transport (MRTN) Misses Q2 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
